Want to join the conversation?
Olivia Tong of BofA ML asks about price mix. CEO Ian Cook replied that $CL's price was greater than its volume in 2Q16. Ian added that for 2016 in total the company's growth, which will be within the 4-7% range, it has been guiding will be more driven towards volume than price on a relative basis to last year.
$YHOO is reporting today after market close. Nobody cares about this stock.
$WBA is yet to receive US anti-trust clearance for its Rite Aid acquisition. The deadline for the deal expires on January 27.
$BMY plunge 7.2%. No credits to the non-acceleration of approval for lung cancer combination treatment.